Back to Search
Start Over
MGMT promoter methylation determined by the MGMT-STP27 algorithm is not predictive for outcome to temozolomide in IDH-mutant anaplastic astrocytomas.
- Source :
-
Neuro-oncology [Neuro Oncol] 2022 Apr 01; Vol. 24 (4), pp. 665-667. - Publication Year :
- 2022
- Subjects :
- Algorithms
Antineoplastic Agents, Alkylating therapeutic use
DNA Methylation
DNA Modification Methylases genetics
DNA Repair Enzymes genetics
Humans
Methylation
Temozolomide therapeutic use
Tumor Suppressor Proteins genetics
Astrocytoma drug therapy
Astrocytoma genetics
Brain Neoplasms drug therapy
Brain Neoplasms genetics
Glioblastoma drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1523-5866
- Volume :
- 24
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Neuro-oncology
- Publication Type :
- Report
- Accession number :
- 35099533
- Full Text :
- https://doi.org/10.1093/neuonc/noac014